Ilika’s larger solid‑state cells signal a turning point in next‑gen battery tech

Ilika Plc

Ilika has begun shipping 10 amp-hour solid-state battery prototypes to automotive customers and partners in adjacent sectors, including defence and industrial systems. These new cells represent a fivefold increase in capacity from its earlier generation, pushing performance into a range that starts to matter in real-world applications.

What sets this milestone apart is that the larger cells have been produced using an automated pilot line, not hand-assembled in a lab. This facility, completed earlier in the year, has already achieved yields of over 90%,an unusually high figure for early-stage solid-state production. That manufacturing consistency gives Ilika a foundation from which to scale, and sends a strong signal that its technology is maturing beyond the research phase.

The decision to automate early anchors a roadmap toward industrialisation and creates optionality around licensing, joint ventures or in-house expansion. The production capability reinforces confidence in the quality of the output, as automation tightens control over variables like layer thickness, electrolyte distribution and interfacial stability, all critical in solid-state designs.

Crucially, the 10 amp-hour format opens the door to subsystem-level trials in electric vehicles, especially for modules intended for premium segments where safety, weight and energy density carry a premium.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search